Form 4 for CADL Candel Therapeutics, Inc.
Accepted 2025-02-25 00:00:00 ET · period of report 2025-02-21 · accession 0001873919-25-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-25 | 2025-02-21 | CADL | Aguilar-Cordova Estuardo | 10% | D - Sale to Iss | $12.02 | -10.6K | 162.9K | -6% | -$127.2K | |
| I | 2025-02-25 | 2025-02-21 | CADL | Aguilar-Cordova Estuardo | 10% | D - Sale to Iss | $12.02 | -10.6K | 120.9K | -8% | -$127.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | CADL | 2025-02-21 | D | D | 10,583 | $12.02 | 162,929 | D | — | — | |
| 2 | Common | CADL | 2025-02-21 | D | D | 10,582 | $12.02 | 120,861 | I By LKA 2022 Revocable Trust | — | — | (F1) Shares of common stock held by spouse LKA 2022 Revocable trust |